Intervention Social Anxiety: Combining Parent-child Treatment
ConditionSocial Anxiety Disorder of Childhood
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age8-16
SponsorLeiden University
About this trial
The aim of this pilot project is to investigate a treatment program for children with social anxiety, in which children and their parents, parallel to each other, follow separate evidence-based interventions. The added value of this pilot project is that the investigators are examining how both programs interact when offered simultaneously.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosis social anxiety
At least 1 parent is willing to participate
Disqualifiers
Currently under treatment for anxiety
Other complaints that need attention first
Not understanding instructions/treatment
Trial design
Design model
Parallel
Treatments tested in this trial
Denken + Doen = Durven
Other interventionDDD is an evidence based cognitive behavioural therapy (CBT)-treatment protocol for children with anxiety. This research will use the modular version of DDD, which means that the therapist will decide which modules she will use based on the specific symptoms and needs of the child. DDD consists of four parts. First, there will be psycho education in which the child learns about how anxiety can arise, when anxiety is normal, and how thoughts, emotions, and behaviour are linked. Second, the child will learn coping strategies for dealing with anxiety. Third, there will be cognitive restructuring by which that the child will learn skills to deal with anxious and negative thoughts, through challenging and experimenting. Finally, there will be exposure. In the exposure sessions, the child will face their fears step by step.
Supportive Parenting for Anxious Childhood Emotions
Other interventionParents will follow the SPACE program. SPACE is a theory driven, evidence-based treatment program of 12 sessions. In a structured way, parents are trained to change their own behaviour as a reaction to the symptoms of their child. First, they are trained to recognise family accommodation and slowly reduce this. Second, this program focuses on the increase in supportive reactions from parents. They are taught to accept the child's feelings, fears, and problems and to trust in the ability of the child to cope with and tolerate anxiety-related problems. These two goals are attained via a sequence of steps in the SPACE manual. Furthermore, SPACE includes additional modules that can be implemented if needed. These provide tools for conquering communal challenges that can arise during the treatment process, including dealing with extremely disruptive behaviour of children and improving parental collaboration.
Treatment groups
9 Participants
are divided into 3 treatment groupsGroup A: 2-week waiting periodActive comparator 2 interventions
Group B: 4-week waiting periodActive comparator 2 interventions
Group C: 6-week waiting periodActive comparator 2 interventions
Trial outcomes
Primary outcomes
1
Change in severity of social anxiety in children
Severity of social anxiety will be assessed using the Anxiety Disorder Interview Schedule (ADIS-V), which will provide a clinician severity rating (CSR)-score. This is a score between 0 and 8, with higher scores indicating a higher severity and interference of anxiety. The ADIS-V will be administered to children and parents.
Time frame
From baseline to the end of treatment and follow-up (1 and 2 months post-treatment)Secondary outcomes
1
Change in anxiety-related symptoms and family accommodation
Children and their parents will fill in a daily experience sampling method (ESM) on their phone to measure thoughts, emotions, and behaviours in the flow of daily life. Children are asked 3 questions, each on a scale from 0 to 8. This sums up to a score between 0 and 24 each day for children. Parents are asked 7 questions which they answer on a scale between 0 and 4, resulting in a score between 0 and 28 each day for parents. Higher scores indicate more anxiety-related symptoms and family accommodation.
Time frame
From baseline to the end of treatment and follow-up (1 and 2 months post-treatment)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Leiden University
Lead sponsor
Leids Universitair Behandel en Expertise Centrum (LUBEC)
Collaborator
GGZ Delfland
Collaborator
Netherlands Organisation for Scientific Research
Collaborator
Source ClinicalTrials.gov